To learn more about the Programs in the NCI Alliance for Nanotechnology in Cancer, select a link below:
Centers of Cancer Nanotechnology Excellence (CCNEs) – NCI has funded nine multi-disciplinary Centers that are the primary components for discovery and tool development of nanotechnology in clinical oncology.
Cancer Nanotechnology Platform Partnerships (CNPP) – NCI has awarded 12 partnerships that are designed to promote and support individual, circumscribed multi-disciplinary research projects that will address major barriers and fundamental questions in cancer using innovative nanotechnology solutions.
Cancer Nanotechnology Training Centers (CNTC) – NCI has named six CNTCs with the goal of educating and training researchers from diverse fields in the use of nanotechnology-based approaches to advance understanding of cancer biology and create new methods and tools for the prevention, diagnosis and treatment of cancer.
Pathway to Independence Awards in Cancer Nanotechnology Research – Seven awards have been funded for the transition of post-doctoral scientists working on cancer nanotechnology from mentored environments to independence.
Nanotechnology Characterization Laboratory (NCL) – The Nanotechnology Characterization Laboratory (NCL) performs and standardizes the pre-clinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government and industry.
Member Guidelines – Access annual and interim report guidelines, as well as site visit guidelines, for the NCI Alliance for Nanotechnology in Cancer Programs.
Past Program Awardees – Past NCI grants supported the work of Centers of Cancer Nanotechnology Excellence, Cancer Nanotechnology Platform Partnerships and Multidisciplinary Research Training and Team Development programs.